Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-25
2007-12-25
Wilson, James O. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S452000, C514S299000, C514S300000
Reexamination Certificate
active
10658121
ABSTRACT:
A novel composition comprises a compound of Formula 1the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers, prodrugs, or mixtures thereof. The composition is of particular utility in the treatment of kinase-implicated disorders.
REFERENCES:
patent: 5593997 (1997-01-01), Dow et al.
patent: 5658857 (1997-08-01), Andree et al.
patent: 5783576 (1998-07-01), Roos et al.
patent: 2003/0212073 (2003-11-01), Currie et al.
patent: 2004/0063715 (2004-04-01), Paruch et al.
patent: 2004/0072835 (2004-04-01), Paruch et al.
patent: 2004/0220189 (2004-11-01), Sun et al.
patent: 2005/0009832 (2005-01-01), Sun et al.
patent: 2005/0054648 (2005-03-01), Mitchell et al.
patent: 2005/0054649 (2005-03-01), Currie et al.
patent: 2005/0085484 (2005-04-01), Mitchell et al.
patent: 2005/0090499 (2005-04-01), Currie et al.
patent: 2005/0101604 (2005-05-01), Currie et al.
patent: 2005/0288295 (2005-12-01), Currie et al.
patent: 0 43 37 609 (1995-05-01), None
patent: 0 480 713 (1992-04-01), None
patent: WO88/04298 (1988-06-01), None
patent: WO95/12594 (1995-05-01), None
patent: WO96/04298 (1996-02-01), None
patent: WO96/34866 (1996-11-01), None
patent: WO99/28322 (1999-06-01), None
patent: WO 01/27119 (2001-04-01), None
patent: WO 02/10170 (2002-02-01), None
patent: WO 02/30428 (2002-04-01), None
patent: WO 02/060492 (2002-08-01), None
patent: WO 02/066481 (2002-08-01), None
patent: WO 02/076985 (2002-10-01), None
patent: WO 03/070732 (2003-08-01), None
patent: WO 03/089434 (2003-10-01), None
patent: WO 2004/022562 (2004-03-01), None
patent: WO 2004/026310 (2004-04-01), None
patent: WO 2004/026877 (2004-04-01), None
patent: WO 2004/072080 (2004-08-01), None
patent: WO 2004/072081 (2004-08-01), None
patent: WO 2005/005429 (2005-01-01), None
patent: WO 2005/014599 (2005-02-01), None
patent: WO 2005/019220 (2005-03-01), None
patent: WO 2005/047290 (2005-05-01), None
Jeffery, Trina K., et al. “Phosphodiesterase III and V Inhibitors on Pulmonary Artery from Pulmonary Hypertensive Rats: Differences between early and Established Pulmonary Hypertension”, Journal of Cardiovascular Pharmacology 1998, vol. 32, No. 2, pp. 213-219.
Hanks, Steven K., “Hanks Classification” 1994, pp. 1-4, http://pkr.sdsc.edu/html/pk—classification/pk—catalytic/pk—hanks—class.html.
Lumma, Jr., William C., et al. Piperazinylimidazo [1,2-a]pyrazines with Selective Affinity for in Vitro a-Adrenergic Receptor Subtypes, J. Med. Chem. 1983, vol. 26, pp. 357-363.
“Protein Kinases in Disease”, http://bioinformatics.weizmann.ac.il/Kinases/pkr/pk—medicine.html, pp. 1-11, 1997.
Stenberg, Kaj A.E. et al. “KinMutBase, a database of human disease-causing protein kinase mutations”, Nucleic Acids Research 2000, vol. 28, pp. 369-371.
Vitse, O. et al., “New Imidazo[1,2-a]pyrazine Derivatives with Bronchodilatory and Cyclic Nucleotide Phosphodiesterase Inhibitory Activities”, Bioorganic & Medicinal Chemistry, 1999, vol. 7, pp. 1059-1065.
Ding et al. (2002) “A Combinatorial Scaffold Approach toward Kinase-Directed Heterocycle Libraries,” J. Am. Chem. Soc., 124(8): 1594-1596.
Restriction Requirement dated Oct. 20, 2004, for U.S. Appl. No. 10/419,682, filed Apr. 21, 2003.
International Search Report dated Oct. 22, 2003, for Application No. PCT/US03/12222, International filing date Apr. 21, 2003.
Written Opinion dated Dec. 5, 2003, for Application No. PCT/US03/12222, International filing date Apr. 21, 2003.
Second Written Opinion dated Apr. 13, 2004, for Application No. PCT/US03/1222, International filing date Apr. 21, 2003.
International Preliminary Examination Report dated Aug. 3, 2004, for Application No. PCT/US03/12222, International filing dated Apr. 21, 2003.
Written Opinion dated Jul. 6, 2004, for Application No. PCT/US03/28329, International filing date Sep. 9, 2003.
International Preliminary Examination Report dated Oct. 27, 2004, for Application No. PCT/US03/28329, International filing date Sep. 9, 2003.
International Search Report and Written Opinion dated Jul. 7, 2004, for Application No. PCT/US2004/003922, International filing date Feb. 10, 2004.
International Search Report and Written Opinion dated Jul. 7, 2004, for Application No. PCT/US2004/003923, International filing date Feb. 10, 2004.
International Search Report and Written Opinion dated Dec. 8, 2004, for Application No. PCT/US2004/021150, International filing date Jun. 30, 2004.
International Search Report and Written Opinion dated Dec. 30, 2004, for Application No. PCT/US2004/018227, International filing date Jun. 4, 2004.
International Search Report and Written Opinion dated Feb. 1, 2005, for Application No. PCT/US2004/025884, International filing date Aug. 11, 2004.
Invitation to Pay Additional Fees with Partial International Search Report dated May 3, 2005, for Application No. PCT/US2004/037433, International filing date Nov. 10, 2004.
International Search Report and Written Opinion dated Jun. 23, 2005, for Application No. PCT/US2004/037433, International filing date Nov. 10, 2004.
International Search Rport dated Sep. 2, 2004; International Application No. PCT/US03/28329; International filing date Sep. 9, 2003.
Currie Kevin S.
Darrow James W.
DeSimone Robert W.
Mitchell Scott A.
Pippin Douglas A.
CGI Pharmaceuticals, Inc.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Ward Paul V.
Wilson James O.
LandOfFree
6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3880915